Breast implant-associated – Anaplastic Large Cell Lymphoma: a call for disease awareness
Open Access
- 1 January 2023
- journal article
- editorial
- Published by Elsevier BV in Hematology, Transfusion and Cell Therapy
- Vol. 45 (1), 124-126
- https://doi.org/10.1016/j.htct.2021.06.019
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Cell of Origin and Immunologic Events in the Pathogenesis of Breast Implant–Associated Anaplastic Large-Cell LymphomaThe American Journal of Pathology, 2019
- The Epidemiology of Breast Implant–Associated Anaplastic Large Cell Lymphoma in Australia and New Zealand Confirms the Highest Risk for Grade 4 Surface Breast ImplantsPlastic and Reconstructive Surgery, 2019
- Breast Implant–Associated Anaplastic Large Cell Lymphoma in Australia and New Zealand: High-Surface-Area Textured Implants Are Associated with Increased RiskPlastic and Reconstructive Surgery, 2017
- U.S. Epidemiology of Breast Implant–Associated Anaplastic Large Cell LymphomaPlastic and Reconstructive Surgery, 2017
- Global Adverse Event Reports of Breast Implant–Associated ALCL: An International Review of 40 Government Authority DatabasesPlastic and Reconstructive Surgery, 2017
- Complete Surgical Excision Is Essential for the Management of Patients With Breast Implant–Associated Anaplastic Large-Cell LymphomaJournal of Clinical Oncology, 2016
- Anaplastic Large Cell Lymphoma Occurring in Women with Breast ImplantsPlastic and Reconstructive Surgery, 2015
- ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomesBlood, 2014
- Breast implant-associated anaplastic large cell lymphoma: sensitivity, specificity, and findings of imaging studies in 44 patientsBreast Cancer Research and Treatment, 2014
- Breast Implant–Associated Anaplastic Large-Cell Lymphoma: Long-Term Follow-Up of 60 PatientsJournal of Clinical Oncology, 2014